LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)

To investigate whether the addition of Fibralign's BioBridge® Collagen Matrix (BioBridge) devices to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper arm.

Trial Details

NCT ID
NCT04606030
Phase
NA
Sponsor
Fibralign Corporation
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • BioBridge® Collagen Matrix
  • Vascularized Lymph Node Transfer (VLNT)
Locations (sample)
  • Chicago, Illinois, United States|41.85003,-87.65005
  • Houston, Texas, United States|29.76328,-95.36327

Key Eligibility Criteria

  • The subject must be a breast cancer survivor, at least 3 years beyond completion of cancer therapy, free of clinical disease, and eligible for surg…
  • Ages 18 to 75 years (inclusive)
  • Eastern Cooperative Oncology Group (ECOG) Performance Status 0 to 2
  • Life expectancy \> 2 years

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →